Mydecine Innovations Group Inc.
MYCOF
$0.0045
-$0.0006-11.77%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.63M | 2.86M | 3.92M | 6.14M | 8.40M |
| Depreciation & Amortization | 0.00 | 900.00 | 3.40K | 7.30K | 13.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.13M | 4.59M | 4.63M | 6.95M | 9.65M |
| Operating Income | -5.13M | -4.59M | -4.63M | -6.95M | -9.65M |
| Income Before Tax | -10.73M | -10.15M | -10.07M | -17.06M | -13.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.73 | -10.15 | -10.07 | -17.06 | -13.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 4.99M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.73M | -10.15M | -10.07M | -17.06M | -8.86M |
| EBIT | -5.13M | -4.59M | -4.63M | -6.95M | -9.65M |
| EBITDA | -5.12M | -4.58M | -4.62M | -6.94M | -9.64M |
| EPS Basic | -0.20 | -0.21 | -0.25 | -0.65 | -0.39 |
| Normalized Basic EPS | -0.09 | -0.10 | -0.12 | -0.22 | -0.37 |
| EPS Diluted | -0.20 | -0.21 | -0.25 | -0.65 | -0.39 |
| Normalized Diluted EPS | -0.09 | -0.10 | -0.12 | -0.22 | -0.37 |
| Average Basic Shares Outstanding | 226.21M | 193.21M | 157.17M | 121.93M | 85.08M |
| Average Diluted Shares Outstanding | 226.21M | 193.21M | 157.17M | 121.93M | 85.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
